Department of Pathology Microbiology and Immunology
-
March 23, 2023
E. coli uses serine to abide acidity
Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies. -
February 20, 2023
Probing hellbender health
Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights. -
February 2, 2023
Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections
-
January 20, 2023
Study reveals new genetic disorder that causes susceptibility to opportunistic infections
An international consortium co-led by Vanderbilt's Rubén Martínez-Barricarte, PhD, has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. -
January 13, 2023
Study identifies potential new approach for treating lupus
A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus. -
January 12, 2023
Antibody “fingerprinting” method potential advance to slow spread of dengue
Vanderbilt researchers have reported a major advance in understanding and potentially preventing dengue, a devastating, mosquito-borne tropical viral infection that is spreading across the globe. -
January 12, 2023
Study may lead to new diabetes, heart disease treatments
Vanderbilt research found that deletion of an autophagy-participating factor named PIK3C3 from the fat cells of mice led to compromised body temperature control, abnormal blood lipid levels, fatty liver and diabetes.